SCI-210

· Neurothera Labs Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCI-210, covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD) [NA]

See pricing